Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)

• Main Authors: Ming-Tao Wen (Author), Jia-Cheng Li (Author), Bo-Wen Lu (Author), Hua-Rong Shao (Author), Pei-Xue Ling (Author), Fei Liu (Author), Gang Li (Author), Di Luo (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BackgroundTeriparatide is approved for osteoporosis. Post-marketing surveillance is critical given its widespread use.ObjectiveTo investigate adverse events (AEs) associated with teriparatide using the FAERS database, compare association strengths for key AEs, and explore potential applications to p...